Search
for
Sort by
Research 871–900 of 1000+
- Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans
- Alopecia Areata: An Updated Review for 2023
- Management of Hair Loss
- Anagen effluvium
- Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
- Quality of Life in Alopecia Areata: A Sample of Tunisian Patients
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- A transcriptomic map of murine and human alopecia areata
- Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Racial Disparities in Hair Loss Episodes in Patients with Alopecia Areata: A Retrospective Cohort Study
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- The Evolving Global Burden of Alopecia Areata in Young Adults: High-Income Nations Bear the Greatest Impact
- Comparison of Therapeutic Efficacy of Topical Tacrolimus 0.1% and Topical Dithranol 0.5% in Treatment of Alopecia Areata
- A scoping review of alopecia areata and its relationship to COVID-19 vaccinations
- The potential of regulatory T cell-based therapies for alopecia areata
- Clinical Findings, Response to Steroid Treatment, and Recurrence Rate in Alopecia Areata Patients with or without a Nonsynonymous Variant of Coiled-Coil Alpha-Helical Rod Protein 1
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- British Hair and Nail Society
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans